5-hydroxytryptophan and fluorodopa f 18

5-hydroxytryptophan has been researched along with fluorodopa f 18 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambrosini, V; Castellucci, P; Fanti, S; Morigi, JJ; Nanni, C1
Giovanella, L; July, M; Santhanam, P; Treglia, G1

Reviews

2 review(s) available for 5-hydroxytryptophan and fluorodopa f 18

ArticleYear
Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP).
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2015, Volume: 59, Issue:1

    Topics: 5-Hydroxytryptophan; Carbon Radioisotopes; Dihydroxyphenylalanine; Gallium Radioisotopes; Humans; Image Enhancement; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals

2015
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
    Clinical physiology and functional imaging, 2018, Volume: 38, Issue:1

    Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Methionine; Multiple Endocrine Neoplasia; Mutation; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin

2018